Clinical trials
Dyslipidemias trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aga Khan University | 3 |
| Asif Ali | 1 |
| Bahria University | 1 |
| GlaxoSmithKline | 1 |
| Khyber Medical University Peshawar | 1 |
| King Edward Medical University | 1 |
| NUR International University | 1 |
| Public Health Foundation of India | 1 |
| Services Hospital, Lahore | 1 |
| Shaheed Zulfiqar Ali Bhutto Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 14 |
| Metabolic Syndrome | 5 |
| Hypertension | 4 |
| Diabetes Mellitus | 3 |
| Obesity | 3 |
| Anemia | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypercholesterolemia | 2 |
| Insulin Resistance | 2 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.